Insider · CIK 0001499075

TATE JEFFREY

Reports to the SEC for 1 company · HIGH SPRINGS, FL

sec.gov

Transactions

Companies

Filings

CIK

0001499075

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-03	Cyclo Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, Chief Operating Officer	AAward	+111K sh	—	—	110,732
2023-10-20	Cyclo Therapeutics, Inc.X Exercise of In-Money	Director, Chief Operating Officer	XExercise of In-Money	+29.9K sh	$0.71	+$21.3K	92,042
2023-10-20	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockX Exercise of In-Money	Director, Chief Operating Officer	XExercise of In-Money	−29.9K sh	$0.13	−$3,742.625	0
2023-10-20	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Operating Officer	PPurchase	+32.9K sh	—	—	32,935
2023-04-20	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Operating Officer	PPurchase	+29.9K sh	$0.71	+$21.3K	62,101
2023-04-20	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Operating Officer	PPurchase	+29.9K sh	$0.13	+$3,742.625	29,941
2023-03-07	Cyclo Therapeutics, Inc.Stock Option (Right to buy)A Award	Director, Chief Operating Officer	AAward	+41K sh	—	—	41,036
2022-05-16	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Operating Officer	PPurchase	+3,000 sh	$2.12	+$6,354	32,160
2022-04-29	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Operating Officer	PPurchase	+300 sh	$2.70	+$810	28,095
2022-04-29	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Operating Officer	PPurchase	+1,065 sh	$2.71	+$2,881.89	29,160
2022-04-28	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Operating Officer	PPurchase	+635 sh	$2.50	+$1,587.5	27,795
2022-02-28	Cyclo Therapeutics, Inc.Stock Options (Right to buy)A Award	Director, Chief Operating Officer	AAward	+31.1K sh	—	—	31,141
2021-08-27	Cyclo Therapeutics, Inc.Stock Option (Right to buy)A Award	Director, Chief Operating Officer	AAward	+23.8K sh	—	—	23,800
2021-03-29	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Operating Officer	PPurchase	+2,000 sh	$7.50	+$15K	27,160
2021-01-13	Cyclo Therapeutics, Inc.A Award	Director, Chief Operating Officer	AAward	+10K sh	—	—	25,160
2020-12-11	Cyclo Therapeutics, Inc.A Award	Director, Chief Operating Officer	AAward	+5,000 sh	—	—	15,160
2020-12-11	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Operating Officer	PPurchase	+5,000 sh	—	—	5,000
2020-04-24	Cyclo Therapeutics, Inc.A Award	Director, Chief Operating Officer	AAward	+50K sh	$0.10	+$5,000	1,015,972
2019-09-27	Cyclo Therapeutics, Inc.A Award	Director, Chief Operating Officer	AAward	+100K sh	—	—	965,972
2018-12-26	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Operating Officer	PPurchase	+25K sh	—	—	865,972
2018-12-26	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Operating Officer	PPurchase	+25K sh	—	—	25,000
2018-05-23	Cyclo Therapeutics, Inc.C Conversion	Director, Chief Operating Officer	CConversion	+100K sh	—	—	840,972
2018-05-23	Cyclo Therapeutics, Inc.Series B Convertible Preferred StockC Conversion	Director, Chief Operating Officer	CConversion	−250 sh	—	—	0
2018-02-01	Cyclo Therapeutics, Inc.A Award	Director, Chief Operating Officer	AAward	+20K sh	—	—	740,972
2017-10-18	Cyclo Therapeutics, Inc.Series B Convertible Preferred StockP Purchase	Director, Chief Operating Officer	PPurchase	+250 sh	—	—	250
2017-10-18	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Operating Officer	PPurchase	+100K sh	—	—	100,000
2017-06-30	Cyclo Therapeutics, Inc.A Award	Director, Chief Operating Officer	AAward	+20K sh	—	—	720,972
2017-03-31	Cyclo Therapeutics, Inc.A Award	Director, Chief Operating Officer	AAward	+20K sh	—	—	700,972
2016-07-22	Cyclo Therapeutics, Inc.A Award	Director, Chief Operating Officer	AAward	+20K sh	—	—	680,972
2016-06-06	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Operating Officer	PPurchase	+100K sh	—	—	660,972
2016-06-06	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Operating Officer	PPurchase	+100K sh	—	—	100,000
2014-11-07	Cyclo Therapeutics, Inc.A Award	Director, Chief Operating Officer	AAward	+20K sh	—	—	560,972
2014-08-01	Cyclo Therapeutics, Inc.A Award	Director, Chief Operating Officer	AAward	+100K sh	—	—	540,972

Recent filings

Accepted (ET)
Jun 54
TATE JEFFREY0001437749-24-019350
SEC(opens sec.gov)
Oct 234
TATE JEFFREY0001437749-23-028701
SEC(opens sec.gov)
Apr 244
TATE JEFFREY0001437749-23-010879
SEC(opens sec.gov)
Mar 94
TATE JEFFREY0001437749-23-006006
SEC(opens sec.gov)
May 164
TATE JEFFREY0001437749-22-012531
SEC(opens sec.gov)
Apr 294
TATE JEFFREY0001437749-22-010226
SEC(opens sec.gov)
Mar 24
TATE JEFFREY0001437749-22-005024
SEC(opens sec.gov)
Aug 304
TATE JEFFREY0001437749-21-021210
SEC(opens sec.gov)
Mar 304
TATE JEFFREY0001437749-21-007615
SEC(opens sec.gov)
Jan 254
TATE JEFFREY0001437749-21-001217
SEC(opens sec.gov)
Dec 144
TATE JEFFREY0001437749-20-025288
SEC(opens sec.gov)
Apr 274
TATE JEFFREY0001437749-20-008578
SEC(opens sec.gov)
Sep 304
TATE JEFFREY0001437749-19-019213
SEC(opens sec.gov)
Dec 264
TATE JEFFREY0001437749-18-022631
SEC(opens sec.gov)

Companies

Cyclo Therapeutics, Inc.Director, Chief Operating Officer

Address

C/O CTD HOLDINGS, INC. 27317 NW 78TH AVENUE

HIGH SPRINGS, FL, 32643